Thomas Kosasa - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 3, 2026

Thomas Kosasa has filed 2 SEC Form 4 filings across 1 company in the last 90 days - buying. Lifetime open-market purchases: $2.15M. Historical track record: 3/5 stars across 7 tracked purchases.

Profile

Thomas Kosasa serves as Director of OneMedNet Corp (ONMD). Kosasa has reported 6 insider filings with the SEC since 2025. The most recent filing was in June 2026.

RoleDirector, 10% Owner
Notability36/100

Board memberships

Reported roles

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating★★★☆☆ (3/5)
Total purchases tracked7
Purchases with forward-return data7
30-day win rate57%
90-day win rate86%
Avg 5-day return+7.68%
Avg 30-day return+33.45%
Avg 90-day return+62.68%
Best 30-day return+135.00%

Trading Pattern

InsiderAlpha's records for Thomas Kosasa go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $239K (9 buys totaling $2.15M). The largest single buy on record is $500K of ONMD in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.

Career & Filing History

Every role Thomas Kosasa has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-15ONMDOneMedNet CorpP - Open-market purchase158.7K$0.63$100K
2026-05-20ONMDOneMedNet CorpP - Open-market purchase268.8K$0.93$250K
2026-04-24ONMDOneMedNet CorpP - Open-market purchase280.9K$0.89$250K
2026-04-24ONMDOneMedNet CorpP - Open-market purchase595.2K$0.84$500K
2025-11-26ONMDOneMedNet CorpA - Grant or award45.0K$0.00
2025-11-26ONMDOneMedNet CorpP - Open-market purchase6.0K$0.93$6K
2025-11-26ONMDOneMedNet CorpP - Open-market purchase581.4K$0.86$500K
2025-11-26ONMDOneMedNet CorpP - Open-market purchase1.19M$0.42$500K
2025-11-26ONMDOneMedNet CorpJ - Other acquisition / disposition2.87M$0.71$2.03M
2025-11-26ONMDOneMedNet CorpJ - Other acquisition / disposition2.12M$0.75$1.60M
2025-11-26ONMDOneMedNet CorpJ - Other acquisition / disposition493.1K$1.14$562K
2025-11-26ONMDOneMedNet CorpP - Open-market purchase55.0K$0.38$21K
2025-11-26ONMDOneMedNet CorpP - Open-market purchase47.0K$0.49$23K
2025-11-26ONMDOneMedNet CorpA - Grant or award45.0K$0.00

Companies - Last 90 Days

Other Insiders Active in the Same Stocks

Insiders who reported open-market trades at the companies Thomas Kosasa has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is Thomas Kosasa?

Thomas Kosasa serves as Director of OneMedNet Corp (ONMD). Kosasa has reported 6 insider filings with the SEC since 2025. The most recent filing was in June 2026.…

How many SEC Form 4 filings has Thomas Kosasa submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Thomas Kosasa been buying or selling stock?

Recorded transactions: 9 open-market purchases ($2.15M) and 0 open-market sales across all tracked filings.

How accurate is Thomas Kosasa's historical track record?

Across 7 tracked purchases, Thomas Kosasa averaged +33.4% avg 30-day return with a 57% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.

Where can I see all of Thomas Kosasa's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Thomas Kosasa profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.